Dai C, Holland E C
Departments of Cell Biology, Neurology, and Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Biochim Biophys Acta. 2001 Aug 31;1551(1):M19-27. doi: 10.1016/s0304-419x(01)00027-0.
Gliomas are primary central nervous system tumors that arise from astrocytes, oligodendrocytes or their precursors. Gliomas can be classified into several groups according to their histologic characteristics, the most malignant of the gliomas is glioblastoma multiforme. In contrast to the long-standing and well-defined histopathology, the underlying molecular and genetic bases for gliomas are only just emerging. Many genetic alterations have been identified in human gliomas, however, establishing unequivocal correlation between these genetic alterations and gliomagenesis requires accurate animal models for this disease. Here we are reviewing the existing animal models for gliomas with different strategies and our current knowledge on the important issues about this disease, such as activation of signal transduction pathways, disruption of cell cycle arrest pathways, cell-of-origin of gliomas, and therapeutic strategies.
神经胶质瘤是起源于星形胶质细胞、少突胶质细胞或其前体细胞的原发性中枢神经系统肿瘤。根据组织学特征,神经胶质瘤可分为几类,其中最恶性的是多形性胶质母细胞瘤。与长期以来明确的组织病理学不同,神经胶质瘤的潜在分子和遗传基础才刚刚显现。在人类神经胶质瘤中已发现许多基因改变,然而,要在这些基因改变与神经胶质瘤发生之间建立明确的关联,需要针对这种疾病的精确动物模型。在此,我们综述了现有的采用不同策略构建的神经胶质瘤动物模型,以及我们目前对该疾病重要问题的认识,如信号转导通路的激活、细胞周期停滞通路的破坏、神经胶质瘤的细胞起源和治疗策略。